Combination of Serratus Anterior and Pectoral Nerve Blocks (PECS II) as Main Anesthetic Method in Breast Cancer Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

17 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-07

Study Completion Date

2023-07-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim of this study is to determine the success of combined serratus anterior and PECS-2 block as the main anesthetic method in breast cancer surgery and also to investigate the patient acceptability of this combination and its relationship with surgeon satisfaction.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Premedication on Postoperative Pain and Anxiety in Breast Cancer Surgery

NCT05647642

Female Patients Under the Age of 65 Who Will Undergo Breast Cancer Surgery

UNKNOWN

Effect of Patient-Anesthesiologist Gender Concordance and Analgesia Method on Postoperative Pain in Mastectomy Patients

NCT07035275

Breast Cancer Mastectomy Postoperative Pain +1 more

RECRUITING

Effects of Anesthesia Techniques on Tissue Oxygenation and Recovery in Lower Abdominal Surgery

NCT07102108

Lower Abdominal Surgery

COMPLETED

PECs for Implantable Cardiac Electronic Device Insertion

NCT05528627

Cardiac Implantable Electronic Device Nerve Block Anesthesia +1 more

COMPLETED NA

AGC Mode vs Minimal Flow in Breast Surgery

NCT05404269

Volatil Agent Consumption Automatic End-tidal Controlled Anesthesia Anesthesia; Functional +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Breast conserving surgery or mastectomy is applied in the surgical treatment of breast cancer. Axillary interventions range from sentinal lymph node biopsy to lymph node dissection. Clinically significant acute pain develops following breast surgery in 35% of patients.

Today, regional anesthesia is widely used as an opioid-sparing strategy in the treatment of acute postoperative pain. New fascial plane blocks have been developed as alternative or complementary techniques for chest wall analgesia, including pectoral nerve blocks (PECS1-2) and serratus plane block.

In order to reduce the risk of perioperative morbidity and mortality and to meet the patient demand, the demand for awake surgery is increasing in institutions.

Therefore, a prospective observational case series was conducted to explain the efficacy, patient acceptability, and surgeon satisfaction of combined serratus anterior and PECS-2 block as the main anesthetic method for breast cancer surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

serratus anterior block and PECs II block combination

The pre-surgery block will be applied. Sensorial block will be evaluated at the surgical incision site with the pinpirick test at 30 minutes after the block, and if the block is successful, surgery will begin.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients between the ages of 18-80 and ASA I-III who will undergo unilateral breast cancer surgery will be included in the study.

Exclusion Criteria

* Patients with previous breast surgery other than excisional biopsy,
* coagulopathy,
* bleeding disease,
* local infection at the injection site,
* history of local anesthetic allergy,
* psychiatric disease (depression, mania, schizophrenia or antipsychotic drug use),
* history of opioid use for more than 4 weeks
* Patients with body mass index (BMI) \>40kg/m2 and
* chest deformity (pectus excavatum and pectus carinatum) will be excluded from the study.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No